Some areas, such as expression profiling, may be getting close to this stage, but for others (for example, custom genotyping and copy-number variation), microarrays may prove more resilient.

Eastern Europe Molecular Diagnostics Market to reach US$ 1.6 Bn by 2035, growing at 3.2% CAGR, driven by advanced testing adoption and healthcare expansion. WILMINGTON, DE, UNITED STATES, August 23, ...

In cancer research, tissue microarrays are used to analyze the frequency of a molecular alteration in different tumor type, to evaluate prognostic markers, and to test potential diagnostic markers.